India begins selecting people for priority coronavirus vaccines

China's Sinopharm offers experimental COVID-19 vaccines to students WSJ

China's Sinopharm offers experimental COVID-19 vaccines to students WSJ

While France is still trying to stem the Covid-19 pandemic, the situation is settling in China: several hundred thousand people have already been vaccinated there.

Russia, the first country to grant regulatory approval for a novel coronavirus vaccine, is also conducting Phase III trials of Sputnik V in Belarus, Venezuela and the United Arab Emirates.

Clinical trials of an experimental vaccine against COVID-19 which is being developed by France's Sanofi and USA biotech firm Translate Bio are on track to begin before the end of the year after positive results in tests on animals.

Sputnik V vaccine, developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Moscow, was registered by Russia's Ministry of Health of Russian Federation on August 11 to become the world's first registered vaccine against COVID-19. "We will start seeing results by January 2021 and the vaccine against SARS-CoV-2 should be ready by the second quarter of 2021", he told The Indian Express. "However, Dr Swaminathan reiterated WHO's position against the unregulated spread of the virus in order to achieve herd immunity".

While speaking on the accessibility conundrum of COVID vaccine Dr JL Meena, Joint Director, NHA, said, "Of course, to have a check on the upsurge of COVID-19 infection, the vaccine is quintessential".

Prince Harry wishes to offer his son 'the childhood he constantly desired'
They are living in an £11 million mansion in California with their young son Archie. The ex-Suits star and the Queen's grandson will discuss online communities.

The selected individuals will be given an estimated 600 million doses. Hopefully, 20-25 crore population will get a vaccine next year. Then people with co-morbidities over 60 years and then the rest of the population, according to the availability of vaccinations.

A government spokesperson did not comment on the Queen's potential role but said: "The science is clear - vaccines save lives, which is why we are leading a global effort to find a Covid-19 vaccine".

The trial was not created to assess efficacy of the vaccine, so it is not possible to say whether the antibody responses induced by the vaccine, called BBIBP-CorV, are sufficient to protect people from SARS-CoV-2 infection. The WHO also took the initiative to simplify the operation.

We need to persevere and wait a little while longer.

The proposal also includes a plan to track the latest vaccine stock position, temperature at storage facility, geotag health centres, and maintain facility-level dashboard for delivery across India.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.